Atorvastatin Calcium Tablet
Product Images NDC 68180-637

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68180-637). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

348a1a28 8e01 4e17 8df6 04d0987b2dcb 01

Chemical structure of Atorvastatin Calcium, depicted as a molecular diagram including its calcium salt form with three water molecules (Ca2+ . 3H2O).*

FDA Label Image

348a1a28 8e01 4e17 8df6 04d0987b2dcb 02

A cumulative incidence line graph comparing Atorvastatin with placebo over 3.5 years. The y-axis represents cumulative incidence percentage, ranging from 0 to 4.0%. The x-axis represents years from 0 to 3.5. Solid line represents Atorvastatin, dashed line represents placebo. Numeric annotation shows hazard ratio (HR=0.64, 95% CI 0.50-0.83) and p-value (p=0.0005).*

FDA Label Image

348a1a28 8e01 4e17 8df6 04d0987b2dcb 03

A line chart comparing cumulative hazard percentages over time for placebo versus Atorvastatin, showing lower risk with Atorvastatin during up to four years of follow-up. The y-axis represents cumulative hazard percentage, and the x-axis shows time to first primary endpoint in years.*

FDA Label Image

348a1a28 8e01 4e17 8df6 04d0987b2dcb 04

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time (in years) for Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The graph includes hazard ratio (HR 0.78 [0.69-0.89]) and P-value (0.0002).*

FDA Label Image

348a1a28 8e01 4e17 8df6 04d0987b2dcb 05

Atorvastatin Calcium Tablets, USP 10 mg oral tablets packaging label from Lupin Pharmaceuticals, Inc. The label indicates 30 tablets per package, with storage instructions and manufacturing details for Lupin Pharmaceuticals in Baltimore, Maryland, and Lupin Limited in Nagpur, India. The label shows NDC 68180-635-06 and is marked Rx only.*

FDA Label Image

348a1a28 8e01 4e17 8df6 04d0987b2dcb 06

Label for Atorvastatin Calcium Tablets, USP 20 mg oral tablets, containing 30 tablets per package. The product is manufactured by Lupin Limited in India and labeled for Lupin Pharmaceuticals, Inc. Directions mention storage at 25°C with permitted excursions, and it states the tablet is film-coated. The label includes NDC 68180-636-06 and barcode.*

FDA Label Image

348a1a28 8e01 4e17 8df6 04d0987b2dcb 07

Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets label by Lupin Pharmaceuticals, Inc. The label indicates a package of 30 tablets for oral use, with storage instructions and manufacturing details from Lupin Limited in India and Lupin Pharmaceuticals in Maryland, USA. The label includes the NDC number 68180-637-06 and emphasizes prescription-only status.*

FDA Label Image

348a1a28 8e01 4e17 8df6 04d0987b2dcb 08

Atorvastatin Calcium Tablets, USP 80 mg oral tablets label by Lupin Pharmaceuticals, Inc. The label states 30 tablets per container and includes storage instructions, manufacturer information, and an NDC barcode. The label highlights the strength as 80 mg and specifies prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.